Debut Plus

₹2,200.8

▲ +3.52 +0.16%

As of 10 Sept 2026 · delayed

NSE Listed · Pharmaceuticals

Corona Remedies Limited (CORONA)

Volume: 3,54,692Avg Vol 1W: 1,29,569Avg Vol 1M: 44,30952W Range:₹1,336.6₹2,270.1
NSE BSE www.coronaremedies.com AI Report
Key Ratios
Checked 7h ago
Market Cap₹13,460 Cr
Current Price₹2,200.8
Previous Close₹2,197.28
High / Low (52w)₹2,270.1 / ₹1,336.6
Volume3,54,692
Avg Vol (1W)1,29,569
Avg Vol (1M)44,309
Stock P/E63.42
Book Value₹122.12
Dividend Yield46%
ROE24.79%
ROA16.52%
Revenue (TTM)—
Revenue Growth17.93%
Profit Margin13.46%
Total Debt₹16 Cr
Shares Outstanding6 Cr
Face Value₹10
EPS (TTM)₹34.7
P/B18.02
Debt / Equity0.19
50 DMA₹2,085.86
200 DMA—
Day change+0.16%
Price Chart
₹2,200.8▲ 53.00% · 1Y
₹2201₹13481.3Cr
2025-12-15
2026-09-10

20-day avg volume: 47K shares

Pros
  • Healthy return on equity of 24.8%.
  • Pays a dividend yield of 46.0%.
  • Company is almost debt-free.
  • Revenue grew 20% YoY.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 63.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹314 Cr₹298 Cr₹294 Cr₹347 Cr₹361 Cr₹342 Cr₹353 Cr₹422 Cr
EBITDA₹60 Cr₹60 Cr₹46 Cr₹63 Cr₹72 Cr₹76 Cr₹56 Cr₹83 Cr
Net Profit₹43 Cr₹45 Cr₹32 Cr₹46 Cr₹52 Cr₹41 Cr₹45 Cr₹60 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹1,202 Cr₹294 Cr₹347 Cr₹361 Cr₹342 Cr₹353 Cr₹1,414 Cr₹422 Cr
EBITDA₹209 Cr₹46 Cr₹63 Cr₹72 Cr₹76 Cr₹56 Cr₹266 Cr₹83 Cr
Net Profit₹149 Cr₹31 Cr₹46 Cr₹52 Cr₹41 Cr₹45 Cr₹185 Cr₹60 Cr
EPS24.43—————30.27—
Balance Sheet
MetricMar 2020Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹396 Cr₹511 Cr₹595 Cr₹831 Cr₹930 Cr₹1,205 Cr
Total Liabilities₹127 Cr₹190 Cr₹187 Cr₹350 Cr₹324 Cr₹458 Cr
Equity₹269 Cr₹321 Cr₹409 Cr₹480 Cr₹606 Cr₹747 Cr
Total Debt₹18 Cr₹17 Cr————
Cash Flow
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹99 Cr₹129 Cr₹175 Cr₹234 Cr₹279 Cr
Investing₹-66 Cr₹-50 Cr₹-267 Cr₹-84 Cr₹-256 Cr
Financing₹-30 Cr₹-45 Cr₹99 Cr₹-107 Cr₹25 Cr
Free Cash Flow₹99 Cr₹129 Cr₹175 Cr₹234 Cr₹279 Cr
Shareholding
Promoter 69% Institutions 16.53% Public 14.48%
Efficiency & Working Capital
ROCE27.1%
Interest Coverage35.5
Dividend Payout—
Debtor Days38 d
Inventory Days33 d
Payable Days38 d
Cash Conversion Cycle32 d
Working Capital Days70 d
Shareholding Details

As of 2026-06-30

Promoter69%
FII3.6%
DII12.9%
Institutions16.5%
Public14.5%
Promoter Pledge0%
No. of Shareholders20,185
Shareholding Pattern

Quarterly — figures in %. Latest 5 quarters.

PeriodApr 2025Apr 2025Dec 2025Mar 2026Jun 2026
Promoters72.5%72.5%69%69%69%
FIIs0%0%1.8%2.2%3.6%
DIIs27.5%0%6.8%7%12.9%
Public0%27.5%22.4%21.7%14.5%
Promoter Pledge0%0%0%0%0%
No. of Shareholders9931,03519,60920,185
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Ankurbhai K MehtaShareholding of Promoter and Promoter Group22%1.35 Cr
Nirav Kirtikumar MehtaShareholding of Promoter and Promoter Group22%1.35 Cr
Kirtikumar Laxmidas MehtaShareholding of Promoter and Promoter Group20%1.22 Cr
Sepia Investments LimitedPublic Shareholding12.7%77,55,786
Invesco India Smallcap FundPublic Shareholding5.1%30,92,372
Hdfc Trustee Company Limited-hdfc Flexi Cap FundPublic Shareholding4.1%25,06,683
Dipaben Niravkumar MehtaShareholding of Promoter and Promoter Group2%12,22,047
Brinda Ankur MehtaShareholding of Promoter and Promoter Group2%12,22,047
Minaxi Kirtikumar MehtaShareholding of Promoter and Promoter Group1%6,08,567
Hetvi Nirav MehtaShareholding of Promoter and Promoter Group0%0
Vanshaj Niravkumar MehtaShareholding of Promoter and Promoter Group0%0
Jitendrakumar Champaklal VoraShareholding of Promoter and Promoter Group0%0
Chandrika Jitendrakumar VoraShareholding of Promoter and Promoter Group0%0
Nehal Devang VoraShareholding of Promoter and Promoter Group0%0
Heti Darshan KothariShareholding of Promoter and Promoter Group0%0
Vishwa Ankur MehtaShareholding of Promoter and Promoter Group0%0
Jainam Ankur MehtaShareholding of Promoter and Promoter Group0%0
Subodhbhai Vrajlal ParikhShareholding of Promoter and Promoter Group0%0
Shardaben Subodhbhai ParikhShareholding of Promoter and Promoter Group0%0
Pritesh Subodhbhai ParikhShareholding of Promoter and Promoter Group0%0
Kanakben Arvindbhai ShahShareholding of Promoter and Promoter Group0%0
Yogeshbhai Harilal ShahShareholding of Promoter and Promoter Group0%0
Ketan Harilal ShahShareholding of Promoter and Promoter Group0%0
Nemish Harilal ShahShareholding of Promoter and Promoter Group0%0
Nkm Nextgen LlpShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
KIRTIKUMAR LAXMIDAS MEHTAChairman(Non Exe)&Dir(Non-Ind)2026
NIRAVKUMAR KIRTIKUMAR MEHTAED / MD / CEO / Promoter2026
ANKUR KIRTIKUMAR MEHTAED / Joint MD / Promoter2026
VIRAL BHUPENDRABHAI SITWALAE D & Wholetime Director2026
Ameet DesaiIndependent Non Exe. Director2026
Monica KanugaIndependent Non Exe. Director2026
Shirish Gundopant BelapureIndependent Non Exe. Director2026
Bhaskar Vemban IyerIndependent Non Exe. Director2026
Chetna DarajiyaCompany Sec. & Compli. Officer2026
Segments — Product
SegmentRevenueShare
Pharmaceuticals₹0 Cr—
Segments — Geography
RegionRevenueShare
In India₹1,152 Cr96.3%
Outside India₹44 Cr3.7%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10616161
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-31Board Meetings—
dividend2026-06-19₹10.0 (100.0%)Final
dividend2026-06-19₹10 (100%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202605012221
2026000104
202605010218
Insider / Designated-Person Trades

14 recent disclosure(s)

Ranjanben Kirtisinh ParmarAcquisition · 75
Ranjanben Kirtisinh ParmarAcquisition · 90
Kirtisinh Manoharsinh ParmarAcquisition · 43
Kirtisinh Manoharsinh ParmarAcquisition · 2
Kirtisinh Manoharsinh ParmarAcquisition · 50
Kirtisinh Manoharsinh ParmarAcquisition · 1
Company Information
Incorporated2004
ChairmanKIRTIKUMAR LAXMIDAS MEHTA
AuditorDeloitte Haskins & Sells LLP
Investor Email[email protected]
🌐 www.coronaremedies.com ↗

📍 Corona House C-Mondeal Busines, #NAME?, Ahmedabad, Gujarat, 380059

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Control Print LimitedCool Caps Industries Ltd.Coral India Finance & Housing Ltd.Waterways Leisure Tourism LimitedCords Cable Industries Ltd.Coromandel International Ltd.Cosmo First LimitedCountry Condo S LimitedCP Capital LimitedCareer Point Edutech Ltd.Captain Polyplast LimitedAditya Infotech LimitedAll “C” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search